Erythema Dyschromicum Perstans Response to Isotretinoin
Authors:
- 1 July 2016
- journal article
- case report
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 152 (7) , 841-2
Abstract
Case Report from JAMA Dermatology — Erythema Dyschromicum Perstans Response to IsotretinoinKeywords
This publication has 4 references indexed in Scilit:
- Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot studyJournal of Dermatological Treatment, 2011
- Ashy dermatoses – a critical review of the literature and a proposed simplified clinical classificationInternational Journal of Dermatology, 2008
- Uses and complications of isotretinoin therapyJournal of the American Academy of Dermatology, 2001
- Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapyArchives of Dermatology, 1997